Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affamed, Amgen, Antengene, Axsome, Biogen, Biomarin, Bluerock Clover, Denali, Eledon, Endeavor, Eureka, Fortress, Horizon, I-Mab, Kazia, Lipigon, Memo, Pai, Pharnext, Polypid, Rhovac, Sirnaomics.